Business Services

Caladrius Biosciences

$2.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-6.73%) Today
+$0.02 (+0.96%) As of 12:38 PM UTC after-hours

Why Robinhood?

You can buy or sell CLBS and other stocks, options, and ETFs commission-free!

About CLBS

Caladrius Biosciences, Inc. Common Stock, also called Caladrius Biosciences, is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Its product pipeline includes CLBS12, CLBS14, CLBS16, and CLBS03. The company was founded on September 18, 1980 and is headquartered in Basking Ridge, NJ. The listed name for CLBS is Caladrius Biosciences, Inc. Common Stock.

CEO
David J. Mazzo
Employees
27
Headquarters
Basking Ridge, New Jersey
Founded
1980
Market Cap
41.43M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
14.83M
High Today
$2.20
Low Today
$2.03
Open Price
$2.11
Volume
1.67M
52 Week High
$4.89
52 Week Low
$1.05

Collections

CLBS Earnings

-$0.49
-$0.33
-$0.16
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

BKSB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure